Download PDF
CC BY-NC-ND 4.0 · Indian J Plast Surg 2012; 45(02): 291-301
DOI: 10.4103/0970-0358.101301
Review Article
Association of Plastic Surgeons of India

Improved wound management by regulated negative pressure-assisted wound therapy and regulated, oxygen- enriched negative pressure-assisted wound therapy through basic science research and clinical assessment

Moris Topaz
Plastic Surgery Unit, Hillel Yaffe Medical Center, Hadera, Department of Chemistry, Bar Ilan University, Ramat Gan
› Author Affiliations
Further Information

Publication History

Publication Date:
27 November 2019 (online)

Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Regulated negative pressure-assisted wound therapy (RNPT) should be regarded as a state-of-the-art technology in wound treatment and the most important physical, nonpharmaceutical, platform technology developed and applied for wound healing in the last two decades. RNPT systems maintain the treated wound′s environment as a semi-closed, semi-isolated system applying external physical stimulations to the wound, leading to biological and biochemical effects, with the potential to substantially influence wound-host interactions, and when properly applied may enhance wound healing. RNPT is a simple, safe, and affordable tool that can be utilized in a wide range of acute and chronic conditions, with reduced need for complicated surgical procedures, and antibiotic treatment. This technology has been shown to be effective and safe, saving limbs and lives on a global scale. Regulated, oxygen-enriched negative pressure-assisted wound therapy (RO-NPT) is an innovative technology, whereby supplemental oxygen is concurrently administered with RNPT for their synergistic effect on treatment and prophylaxis of anaerobic wound infection and promotion of wound healing. Understanding the basic science, modes of operation and the associated risks of these technologies through their fundamental clinical mechanisms is the main objective of this review.

KEY WORDS

Regulated negative pressure-assisted wound therapy - regulated - oxygen-enriched negative pressure-assisted wound therapy - vacuum - wound healing
 
  • 1 Argenta LC, Morykwas MJ, Marks MW, DeFranzo AJ, Molnar JA, David LR. Vacuum assisted closure: State of clinic art. Plast Reconstr Surg 2006;117:127S-42S.
  • 2 Topaz M. Chapter 35: Role of regulated negative pressure therapy in wound healing. In: Sarabahi S, Tiwari VK, editors. Principal and practice of wound care. Jaypee Bros Pubs, New Delhi, India; 2012;401-31.
  • 3 Moues CM, Vos MC, Van den Bemd G, Stijnen T, Hovius SE. Bacterial load in relation to vacuum-assisted closure wound therapy: A prospective randomized trial. Wound Repair Regen 2004;12:11-7.
  • 4 Wagner S, Coerper S, Fricke J, Hunt TK, Hussain Z, Elmlinger MW, et al. Comparison of inflammatory and systemic sources of growth factors in acute and chronic human wounds. Wound Repair Regen 2003;11:253-60.
  • 5 Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: A new method for wound control and treatment. Animal studies and basic foundation. Ann Plast Surg 1997;38:553-62.
  • 6 Fabian TS, Kaufman HJ, Lett ED, Thomas JB, Rawl DK, Lewis PL, et al. The evaluation of subatmospheric pressure and hyperbaric oxygen in ischemic full-thickness wound healing. Am Surg 2000;66:1136-43.
  • 7 Morykwas MJ, Faler BJ, Pearce DJ, Argenta LC. Effects of varying levels of subatmospheric pressure on the rate of granulation tissue formation in experimental wounds in swine. Ann Plast Surg 2001;47:547-51.
  • 8 Chen SZ, Li J, Li XY, Xu LS. Effects of vacuum-assisted closure on wound microcirculation: An experimental study. Asian J Surg 2005;28:211-7.
  • 9 Kairinos N, Voogd AM, Botha PH, Kotze T, Kahn D, Hudson DA, et al. Negative-pressure wound therapy II: Negative-pressure wound therapy and increased perfusion. Just an illusion? Plast Reconstr Surg 2009;123:601-12.
  • 10 Sjögren J, Gustafsson R, Koul B, Ingemansson R. Selective mediastinal tamponade to control coagulopathic bleeding. Ann Thorac Surg 2003;75:1311-3.
  • 11 Ilizarov GA. The tension-stress effect on the genesis and growth of tissues. Part I. The influence of stability of fixation and soft-tissue preservation. Clin Orthop Relat Res 1989;238:249-81.
  • 12 Chin MS, Ogawa R, Lancerotto L, Pietramaggiori G, Schomacker KT, Mathers JC, et al. In vivo acceleration of skin growth using a servo-controlled stretching device. Tissue Eng Part C Methods 2010;16:397-405.
  • 13 Topaz M, Bisker O, Litmanovich M, Keren G. Application of regulated oxygen-enriched negative pressure-assisted wound therapy in combating anaerobic infections. Eur J Plast Surg Published online 2010 Oct 21.
  • 14 In: Finegold SM, George WL, editors. Anaerobic Infections in Humans. San Diego, CA: Academic Press; 1989.
  • 15 Fredette V, Plante C, Roy A. Numerical data concerning the sensitivity of anaerobic bacteria to oxygen. J Bacteriol 1967;93:2012-7.
  • 16 Loesche WJ. Oxygen sensitivity of various anaerobic bacteria. Appl Microbiol 1969;18:723-7.
  • 17 Zahar JR, Goveia J, Lesprit P, Brun-Buisson C. Severe soft tissue infections of the extremities in patients admitted to an intensive care unit. Clin Microbiol Infect 2005;11:79-82.
  • 18 Kaide CG, Khandelwal S. Hyperbaric oxygen: Applications in infectious disease. Emerg Med Clin North Am 2008;26:571-95.
  • 19 Gottrup F. Oxygen in wound healing and infection. World J Surg 2004;28:312-5.
  • 20 de Geus HR, van der Klooster JM. Vacuum-assisted closure in the treatment of large skin defects due to necrotizing fasciitis. Intensive Care Med 2005;31:601.
  • 21 Oczenski W, Waldenberger F, Nehrer G, Kneifel W, Swoboda H, Schwarz S. Vacuum-assisted closure for the treatment of cervical and mediastinal necrotizing fasciitis. J Cardiothorac Vasc Anesth 2004;18:336-8.
  • 22 Rodriguez PG, Felix FN, Woodley DT, Shim EK. The role of oxygen in wound healing: A review of the literature. Dermatol Surg 2008;34:1159-69.
  • 23 Gwan-Nulla DN, Casal RS. Toxic shock syndrome associated with the use of the vacuum-assisted closure device. Ann Plast Surg 2001;47:552-4.
  • 24 V.A.C. Therapy indications and contraindications. Available from: http://www.kci1.com/KCI1/indications and contraindications. [Last accessed August 6, 2012.]
  • 25 FDA Preliminary Public Health NotificationFNx01: Serious complications associated with negative pressure wound therapy systems. Available from: http://www.fda.gov/Medical Devices/Safety/Alerts and Notices/Public Health Notifications/ucm190658.htm. [Last accessed August 6, 2012.]
  • 26 U.S. Food and Drug Administration. Preliminary Public Health Notification: Serious complications associated with negative pressure wound therapy systems (FDA web site). Date: November 13, 2009. Available from: http://www.fda.gov/Medical Devices/Safety/Alerts and Notices/Public Health Notifications/ucm190658.htm. [Last accessed August 6, 2012.].